Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03066661
Title Expanded Access to Entrectinib for Cancers With NTRK1/2/3, ROS1, or ALK Gene Fusions
Recruitment No longer available
Gender both
Phase Expanded access
Variant Requirements Yes
Sponsors Ignyta, Inc.
Indications
Therapies
Age Groups: adult | child | senior
Covered Countries USA

Facility Status City State Zip Country Details
1-844-Startrk (782-7875) San Diego California 92121 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field